Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends
New

VYNE
VYNE Therapeutics Inc
stock NASDAQ

Market Open
5/23/2022 3:17:37 PM EDT
0.3950USD-1.275%(-0.0051)273,241
0.3450Bid   0.4148Ask   0.0698Spread IEX
Pre-market
1969-12-31
0.00USD-100.000%(-0.40)0
After-hours
1969-12-31
0.00USD0.000%(0.00)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
22.874M
Industry
Biotechnology
Next Earnings
2022-08-11 (79d)
Last Split
2021-02-161for4reverse
Jan 19, 2022
08:04AM EST  VYNE Therapeutics Announces Phase 1b Data For FMX114 from Phase 1b/2a Trial For Treatment Of Mild-To-Moderate Atopic Dermatitis   Benzinga
08:00AM EST  Systemic bioavailability of JAK inhibitor (tofacitinib) and S1P receptor modulator (fingolimod) in topical formulation substantially lower compared to oral equivalents   GlobeNewswire Inc
Jan 13, 2022
11:45AM EST  VYNE Therapeutics Divests Topical Minocycline Assets; Transaction Includes Cash Payments Of $25M And Potential Milestones Of Up To $450M   Benzinga
07:00AM EST  Transaction includes cash payments of $25 million and potential milestones of up to $450 million   GlobeNewswire Inc
Jan 3, 2022
08:00AM EST  VYNE Therapeutics Inc. (Nasdaq: VYNE) (VYNE or the Company) today announced that management will participate in one-on-one investor meetings at the LifeSci Partners 11th Annual Corporate Access Event, to be held virtually January 5-7, 2022.   GlobeNewswire Inc
More News
Stats
Avg. Vol. 10 Day
322,107
Avg. Vol. 30 Day
417,645
Employees
28
Market Cap
22,873,853
Shares Out.
57,908,489
Float
54,103,760
On/Off Exchange
38%/62%
6 Month Beta
1.50
1 Year Beta
1.40
2 Year Beta
1.41
3 Year Beta
0.98
52 Week Low
0.34
52 Week High
4.24
SMA50
0.47
SMA200
0.75
1 Week
-3.66%
1 Month
-7.06%
3 Month
-23.54%
6 Month
-62.74%
1 Year
-88.87%
2 Year
-95.89%
5 Year
-99.65%
Profile
VYNE's mission is to improve the lives of patients by developing proprietary, innovative and differentiated therapies in dermatology and beyond.

VYNE Stock Summary

VYNE Therapeutics Inc (NASDAQ:VYNE) stock price today is $0.3950, and today's volume is 273,241. VYNE is down -1.275% today. The 30 day average volume is 417,645. VYNE market cap is 22.874M with 57,908,489 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter @chartexchange_
© 2020 - 2022 ChartExchange LLC